title: Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma.
authors.affiliation: Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
authors.forename: Angela
authors.initials: A
authors.lastname: Ferrari
authors.forename: Mario
authors.initials: M
authors.lastname: Luppi
authors.forename: Andrea
authors.initials: A
authors.lastname: Lazzerini
authors.forename: Leonardo
authors.initials: L
authors.lastname: Potenza
authors.forename: Gian Maria
authors.initials: GM
authors.lastname: Cavallini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Torelli
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005134:Eye Neoplasms / Q000188:drug therapy / Q000473:pathology*; D017809:Fatal Outcome; D006801:Humans; D007150:Immunohistochemistry; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone